共 120 条
[1]
Brooks R(1996)EuroQol: The current state of play Health Policy 37 53-72
[2]
Kennedy-Martin M(2020)Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines The European Journal of Health Economics 2 8-1109
[3]
Slaap B(2005)EQ-5D in a general population survey—A description of the most commonly reported EQ-5D health states using the SF-36 Quality of Life Research 14 1099-408
[4]
Herdman M(2018)Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys Population Health Metrics 16 14-227
[5]
van Reenen M(2006)Calculating QALYs, comparing QALY and DALY calculations Health Policy and Planning 21 402-1258
[6]
Kennedy-Martin T(2004)National Institute for Clinical Excellence and its value judgments BMJ 329 224-2710
[7]
Greiner W(1996)Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1253-137
[8]
Nordlund A(2016)EQ-5D in Central and Eastern Europe: 2000–2015 Quality of Life Research 25 2693-1736
[9]
Ekberg K(2017)EQ-5D and the EuroQol group: Past, present and future Applied Health Economics and Health Policy 15 127-661
[10]
Kristenson M(2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Quality of Life Research 20 1727-3417